Deep Dive: Access and Commercialisation

Our April issue of ‘Deep Dive’ will concentrate on Access and Commercialisation, with a special focus on improving outcomes with digital health and customer experience.

In addition to articles on launch strategies and optimising market access, we’ll also hear from:

  • Independent healthcare market research and consulting agency Research Partnership
  • Experts in path-to-market strategy and positioning IDEA Pharma
  • Clinical research organisation ICON
  • Online customer advisory board expert Impetus Digital

The issue will also feature insights from clinical stage gene therapy company bluebird bio, and independent health economist and policy specialist Leela Barham, and we will be presenting expert commentary and key highlights from IQVIA‘s market access summit held in London and eyeforpharma Barcelona, including interviews with Janssen’s Kris Sterkens and LEO Innovation Lab’s John Zibert.

Kind regards,

George Underwood – Editor, Deep Dive: Access and Commercialisation

For the best page-viewing experience, make sure you have your browser at full-screen size. Use the left/right arrow buttons to scroll through the pages or click on the menu icon bottom centre to navigate. You can also share the articles on social media by clicking the icon bottom left at the base of the main navigation or at the end of each article.

Next issue: Access & Commercialisation (April 2019)
Plus: Improving outcomes with digital health • Customer experience

Catch up on recent issues:

R&D Innovation – February 2019
Disruptive Technologies – January 2019
Digital Health Innovation – A Deep Dive special
Oncology – Reflections on ASCO, June 2018
Future Pharma, May 2018
Patient Centricity, April 2018
Digital, December 2017


Your name

Your e-mail

Name receiver

E-mail address receiver

Your message








Your name

Your e-mail

Your message